help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 10, 2007
Endocrinology, doi:10.1210/en.2006-1691
A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/8/3773    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stas, S.
Right arrow Articles by Sowers, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stas, S.
Right arrow Articles by Sowers, J. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SPIRONOLACTONE

Submitted on December 18, 2006
Accepted on April 27, 2007

Mineralocorticoid Receptor Blockade Attenuates Chronic Overexpression of the Renin-Angiotensin-Aldosterone System Stimulation of NADPH Oxidase and Cardiac Remodeling

Sameer Stas, Adam Whaley-Connell, Javad Habibi, Lama Appesh, Melvin R. Hayden, Poorna R. Karuparthi, Mahnaz Qazi, E. Matthew Morris, Shawna A. Cooper, C. Daniel Link, Craig Stump, Meredith Hay, Carlos Ferrario, and James R. Sowers*

University of Missouri School of Medicine, Divisions of Endocrinology and Nephrology, Diabetes and Cardiovascular Lab, and Harry S. Truman VA Medical Center, The University of Arizona Department of Medicine, University of Iowa , Wake Forest University School of Medicine

* To whom correspondence should be addressed. E-mail: sowersj{at}health.missouri.edu.

Renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, hypertrophy, and left ventricular dysfunction. Ang-II and aldosterone (corticosterone in rodents) together generate reactive oxygen species (ROS) via NADPH oxidase, which likely facilitate this hypertrophy and remodeling. This investigation sought to determine whether cardiac oxidative stress and cellular remodeling could be attenuated by in vivo mineralcorticoid receptor (MR) blockade in a rodent model of chronically elevated tissue RAAS, the transgenic TG (mRen2) 27 rat (Ren2). The Ren2 overexpresses the mouse renin transgene with resultant hypertension, insulin resistance, proteinuria, and cardiovascular damage. Young (6-7 week old) male Ren2 and age-matched Sprague-Dawley (SD) rats were treated with spironolactone or placebo for three weeks. Heart tissue reactive oxygen species (ROS), immunohistochemical (IHC) analysis of 3-nitrotyrosine, and NADPH oxidase (NOX) subunits (gp91phox recently renamed NOX2, p22phox, Rac1, NOX1 and NOX4) were measured. Structural changes were assessed with cine MRI, transmission electron microscopy (TEM), and light microscopy. Significant increases in Ren2 septal wall thickness (cine MRI) were accompanied by perivascular fibrosis, increased mitochondria, and other ultrastructural changes visible by light microscopy and TEM. Although there was no significant reduction in systolic blood pressure (SBP), significant improvements were seen with MR blockade on ROS formation and NADPH oxidase subunits (each p<0.05). Collectively, these data suggest that MR blockade, independent of SBP reduction, improves cardiac oxidative stress induced structural and functional changes, which are driven, in part, by AT1R-mediated increases in NADPH oxidase.


Key words: TG (mRen2) 27 rat • Cardiac Remodeling • NADPH oxidase • Oxidative Stress




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. Habibi, A. Whaley-Connell, M. R. Hayden, V. G. DeMarco, R. Schneider, S. D. Sowers, P. Karuparthi, C. M. Ferrario, and J. R. Sowers
Renin Inhibition Attenuates Insulin Resistance, Oxidative Stress, and Pancreatic Remodeling in the Transgenic Ren2 Rat
Endocrinology, November 1, 2008; 149(11): 5643 - 5653.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Wu, M. J. Stevenson, J. M. Brown, E. A. Grunz, T. L. Strawn, and W. P. Fay
C-Reactive Protein Enhances Tissue Factor Expression by Vascular Smooth Muscle Cells: Mechanisms and In Vivo Significance
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 698 - 704.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-a Kim, Y. Wei, and J. R. Sowers
Role of Mitochondrial Dysfunction in Insulin Resistance
Circ. Res., February 29, 2008; 102(4): 401 - 414.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. J. Brown
Aldosterone and Vascular Inflammation
Hypertension, February 1, 2008; 51(2): 161 - 167.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society